Pan, M., Hsu, M., Luo, C., Chen, L., Shan, Y., & Hung, W. (2016). The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer. Oncotarget.
Chicago Stili AlıntıPan, Mei-Ren, Ming-Chuan Hsu, Chi-Wen Luo, Li-Tzong Chen, Yan-Shen Shan, ve Wen-Chun Hung. "The Histone Methyltransferase G9a As a Therapeutic Target to Override Gemcitabine Resistance in Pancreatic Cancer." Oncotarget 2016.
MLA AlıntıPan, Mei-Ren, et al. "The Histone Methyltransferase G9a As a Therapeutic Target to Override Gemcitabine Resistance in Pancreatic Cancer." Oncotarget 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..